ZepboundSouth San Francisco, CA

Zepbound in South San Francisco, CA

In the Pacific region, limited pharmacy competition and distribution costs can affect medication pricing. Zepbound® (Tirzepatide, Injectable pen) by Eli Lilly has been FDA-approved since 2023 for Chronic weight management. Weight Method offers a separate option for South San Francisco residents: licensed California providers evaluate eligible patients via telehealth and prescribe compounded Tirzepatide, dispensed by a U.S.-licensed 503A pharmacy. Compounded Tirzepatide is not FDA-approved. The Weight Method program is priced at $329/month — same pricing regardless of location.

FDA-approved Zepbound prescribed by licensed providers. Delivered to your door.

Take the Free Quiz

Free consultation · No commitment · Results in weeks

Patient
Patient
Patient
Patient
Patient
4.9/5

From 2,000+ patients · South San Francisco is already seeing results

Licensed Providers
FDA-Approved Medications
Free Shipping
HIPAA Compliant
Updated May 2026Medically reviewed by licensed providers

Zepbound in South San Francisco, CA: an FDA-approved GLP-1 medication shown to achieve 15-22% body weight loss in clinical trials. Weight Method offers Zepbound to patients in South San Francisco from $329/month with virtual consultations and direct-to-door shipping.

How does this medication work for weight loss?

For many people in South San Francisco, diet and exercise alone have not produced lasting results — and that is not a failure of willpower. Tirzepatide addresses hormonal drivers involved in body weight regulation. Zepbound® is the FDA-approved Injectable pen Tirzepatide product by Eli Lilly, approved in 2023 for Chronic weight management. Weight Method offers a separate telehealth program: licensed providers evaluate eligible patients and prescribe compounded Tirzepatide, dispensed by a U.S.-licensed 503A pharmacy. Compounded Tirzepatide is not FDA-approved. The program is priced at $329/month, including the evaluation, the medication, ongoing care, and home delivery to South San Francisco.

What treatment options are available locally?

Research suggests Tirzepatide therapy is studied across diverse populations, and outcomes can improve when care is culturally informed. In South San Francisco, Weight Method pairs compounded Tirzepatide treatment (dispensed by a U.S.-licensed 503A pharmacy; compounded Tirzepatide is not FDA-approved) with bilingual support that respects cultural context, from dietary guidance that accounts for traditional foods to communication in the language you are most comfortable with. The program starts at $329/month.

Ready to Get Started?

Answer a few quick questions to see if you qualify.

Check Eligibility

Your Treatment Options

Compounded GLP-1 medications dispensed by U.S.-licensed 503A pharmacies.

Starting at$199/mo
Semaglutide
Most PopularIn Stock

Semaglutide

Compounded semaglutide. Once-weekly subcutaneous injection.

  • Weekly injection
  • Gradual dose increase
  • Provider monitoring
  • Free shipping
Check Eligibility
Tirzepatide
In Stock

Tirzepatide

Compounded tirzepatide. Dual-action GLP-1/GIP, once-weekly subcutaneous injection.

  • Weekly injection
  • Dual hormone action
  • Provider monitoring
  • Free shipping
Check Eligibility

Frequently Asked Questions

Zepbound® is the FDA-approved Injectable pen Tirzepatide product manufactured by Eli Lilly. Weight Method prescribes compounded Tirzepatide, which is prepared by a U.S.-licensed 503A compounding pharmacy under state and federal pharmacy regulations. Compounded Tirzepatide is not FDA-approved and is a different regulatory category from FDA-approved finished drug products. Your Weight Method provider will discuss whether compounded Tirzepatide is an appropriate option based on your medical history.

Yes. Weight Method's licensed providers in California can prescribe compounded Tirzepatide through a fully virtual process. You complete an online health assessment, have a virtual consultation, and if approved, your compounded Tirzepatide is shipped directly to your South San Francisco address. Compounded Tirzepatide is dispensed by a U.S.-licensed 503A pharmacy and is not FDA-approved. There is no need to visit a physical clinic, and the program starts at $329/month.

Zepbound® is a Injectable pen manufactured by Eli Lilly, FDA-approved since 2023 for Chronic weight management. It contains Tirzepatide, which mimics natural incretin hormones to reduce appetite, slow gastric emptying, and help your body regulate hunger. Zepbound® is taken Once weekly. Weight Method does not sell Zepbound®; we are a separate program that prescribes compounded Tirzepatide (dispensed by a U.S.-licensed 503A pharmacy and not FDA-approved) starting at $329/month.

No. Weight Method operates on a direct-pay model with transparent pricing. The compounded Tirzepatide program starts at $329/month and covers your medication, provider consultations, and free delivery to South San Francisco. No insurance claims, no prior authorizations, and no surprise bills. Compounded Tirzepatide is dispensed by a U.S.-licensed 503A pharmacy and is not FDA-approved.

The most common side effects of Tirzepatide are gastrointestinal — mild nausea, decreased appetite, and occasional digestive discomfort. These typically occur during the first few weeks or after dose increases and diminish as your body adjusts. Your Weight Method provider follows a gradual dose-escalation protocol designed to reduce side effects and will monitor your progress throughout treatment. Discuss your full medical history with your provider before starting any GLP-1 therapy.

Start Your Treatment

Consult with a licensed provider in California and start Zepbound from $329/month.

Get Started Now

Free consultation. No commitment.

Other Brands in South San Francisco

Nearby Cities

See More